Tetrahydrobiopterin synthesis and metabolism is impaired in dystrophin‐deficient mdx mice and humans
- 13 February 2021
- journal article
- research article
- Published by Wiley in Acta Physiologica
- Vol. 231 (4), e13627
- https://doi.org/10.1111/apha.13627
Abstract
Aim Loss of dystrophin causes oxidative stress and affects nitric oxide synthase‐mediated vascular function in striated muscle. Because tetrahydrobiopterin is an antioxidant and co‐factor for nitric oxide synthase, we tested the hypothesis that tetrahydrobiopterin would be low in mdx mice and humans deficient for dystrophin. Methods Tetrahydrobiopterin and its metabolites were measured at rest and in response to exercise in Duchenne and Becker muscular dystrophy patients, age‐matched male controls as well as wildtype, mdx and mdx mice transgenically overexpressing skeletal muscle‐specific dystrophins. Mdx mice were also supplemented with tetrahydrobiopterin and pathophysiology was assessed. Results Duchenne muscular dystrophy patients had lower urinary dihydrobiopterin + tetrahydrobiopterin/specific gravity1.020 compared to unaffected age‐matched males and Becker muscular dystrophy patients. Mdx mice had low urinary and skeletal muscle dihydrobiopterin + tetrahydrobiopterin compared to wildtype mice. Mdx mice overexpressing dystrophins that localize neuronal nitric oxide synthase, restored dihydrobiopterin + tetrahydrobiopterin in mdx mice to wildtype levels while utrophin overexpression did not. Mdx mice and Duchenne muscular dystrophy patients did not increase tetrahydrobiopterin during exercise and in mdx mice tetrahydrobiopterin deficiency was likely due to lower levels of sepiapterin reductase in skeletal muscle. Tetrahydrobiopterin supplementation improved skeletal muscle strength, resistance to fatiguing and injurious contractions in vivo, increased utrophin and capillary density of skeletal muscle and lowered cardiac muscle fibrosis and left ventricular wall thickness in mdx mice. Conclusion These data demonstrate that impaired tetrahydrobiopterin synthesis is associated with dystrophin loss and treatment with tetrahydrobiopterin improves striated muscle histopathology and skeletal muscle function and in mdx mice.Keywords
Funding Information
- Muscular Dystrophy Association (349549)
- National Institutes of Health (R01 AR042423, T32‐AG029796, T32‐AR007612, R01 AR049899)
- University of Minnesota
This publication has 80 references indexed in Scilit:
- Skeletal Muscle NADPH Oxidase Is Increased and Triggers Stretch-Induced Damage in the mdx MousePLOS ONE, 2010
- Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathyInternational Journal of Experimental Pathology, 2010
- PhenylketonuriaThe Lancet, 2010
- Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin‐null miceThe Journal of Pathology, 2010
- Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx miceHuman Molecular Genetics, 2010
- Effect of VEGF on the Regenerative Capacity of Muscle Stem Cells in Dystrophic Skeletal MuscleMolecular Therapy, 2009
- Sarcolemma-localized nNOS is required to maintain activity after mild exerciseNature, 2008
- l-Arginine Decreases Inflammation and Modulates the Nuclear Factor-κB/Matrix Metalloproteinase Cascade in Mdx Muscle FibersThe American Journal of Pathology, 2008
- Ageing diminishes endothelium‐dependent vasodilatation and tetrahydrobiopterin content in rat skeletal muscle arteriolesJournal Of Physiology-London, 2008
- Primary Role of Functional Ischemia, Quantitative Evidence for the Two-Hit Mechanism, and Phosphodiesterase-5 Inhibitor Therapy in Mouse Muscular DystrophyPLOS ONE, 2007